Skip to main content
Equibles
LMAT logo

LMAT · Lemaitre Vascular Inc

Track LMAT — free

Use LMAT with AI

Ask our own analyst here, or connect this data to the AI you already use.

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

or use your own AI

The free Equibles MCP server lets any client query SEC filings, earnings calls, KPIs, holdings and prices directly — read-only, OAuth-secured, cited to the filing.

ChatGPT Claude Gemini
Server URL
https://mcp.equibles.com/mcp
All connection guides →
$80.67 +0.18 (+0.22%) At close · Sep 4
S&P 600 member Russell 2000 member Rebalance outlook locked
Market Cap
$1.84B
Shares
22.87M

LMAT metrics

85 of 114 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$80.67
Market cap
$1.84B

Price action

19 metrics
Price change (1W)
+0.3%
Price change (30D)
-1.0%
Price change (3M)
-14.6%
Price change (6M)
-24.9%
Price change (YTD)
-0.5%
Price change (1Y)
-16.9%
Trailing year
Price change (5Y)
+37.9%
52-week high
$117.39
52-week low
$78.97
Change from 52-week high
-31.3%
Change from 52-week low
+2.2%
Annualized volatility
44.8%
Beta
0.5
RSI (14D)
38.9
Price vs SMA 50
-12.1%
Price vs SMA 200
-15.1%
Avg volume (3M)
365,181
Relative volume
0.5
Average dollar volume
$33.08M

Company

3 metrics
Sector
Healthcare
Industry
Medical Instruments & Supplies
Shares outstanding
22.87M

Valuation

12 metrics
P / E (TTM)
28.2
Trailing earnings · reciprocal yield 3.5%
PEG ratio
1.2
EV / revenue
—
EV / EBITDA
—
EV / EBIT
—
P / sales
7.0×
reciprocal yield 14.2%
P / book
4.4
reciprocal yield 22.8%
FCF yield
4.0%
TTM · current market cap
Buyback yield
0.1%
P / FCF
25.0
reciprocal yield 4.0%
P / operating cash flow
22.2
reciprocal yield 4.5%
Earnings yield
3.6%

Historical valuation

8 metrics
P / E historical average (3Y)
45.1×
reciprocal yield 2.2%
P / E historical average (5Y)
45.7×
reciprocal yield 2.2%
EV / revenue historical average (3Y)
—
EV / revenue historical average (5Y)
—
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—

Dividends & buybacks

7 metrics
Dividend yield
1.2%
Trailing 12 months
Payout ratio
31.2%
Shareholder yield
1.2%
Dividend / share (TTM)
$0.95
Dividend growth YoY
+25.0%
Dividend growth streak
5
Last ex-dividend
2026-08-20

Earnings calendar

2 metrics
Next earnings
—
Last earnings
2026-08-04

Profitability

9 metrics
Gross margin
72.9%
Operating margin
29.5%
Trailing 12 months
Net margin
25.0%
Gross profit (TTM)
$191.31M
Operating profit (TTM)
$77.32M
Net income (TTM)
$65.67M
Trailing 12 months
Diluted EPS (TTM)
$2.86
FCF margin
28.1%
Effective tax rate
22.5%

Per share

11 metrics
Revenue per diluted share (TTM)
—
Gross profit per diluted share (TTM)
—
Operating profit per diluted share (TTM)
—
EBITDA per diluted share (TTM)
—
Net income per diluted share (TTM)
—
Operating cash flow per diluted share (TTM)
—
Free cash flow per diluted share (TTM)
—
Capital expenditures per diluted share (TTM)
—
R&D per diluted share (TTM)
—
Stock compensation per diluted share (TTM)
—
Book value per share
—

Growth

11 metrics
Revenue growth YoY
+9.6%
Year over year
Net income growth YoY
+23.7%
Revenue (TTM)
$262.43M
Trailing 12 months
EPS growth YoY
+23.3%
Shares change YoY
+7.2%
Year over year · more shares
Revenue CAGR (3Y)
+15.6%
Revenue CAGR (5Y)
+14.0%
EPS CAGR (3Y)
+39.4%
EPS CAGR (5Y)
+19.4%
FCF CAGR (3Y)
+49.8%
FCF CAGR (5Y)
+18.5%

Quality

14 metrics
Return on equity
15.6%
Return on assets
10.3%
Debt / equity
—
Current ratio
16.3
EBITDA (TTM)
$87.82M
Free cash flow (TTM)
$73.83M
Quick ratio
—
Interest coverage
14.9
Net debt / EBITDA
-0.3
Return on invested capital
—
Trailing 12 months
Net cash
$26.62M
Latest balance sheet
Cash & equivalents
$26.62M
Total assets
$640.55M
Total debt
—

Cash flow & spend

7 metrics
Operating cash flow (TTM)
$82.98M
Capital expenditures (TTM)
$9.15M
R&D (TTM)
$15.41M
SG&A (TTM)
—
Stock compensation (TTM)
$7.86M
R&D / revenue
5.9%
Stock compensation / revenue
3.0%

Ownership (13F)

3 metrics
13F filers
328
13F filer change QoQ
-14
Institutional ownership
100.0%

Short interest

3 metrics
Short interest
7.0%
Latest settlement · 2.8 days to cover
Days to cover
2.8d
Short-squeeze score
56 / 100

Insider activity

2 metrics
Net insider buying (90D)
—
Insider-sentiment score
—

Risk flags

1 metrics
Going concern
—
Key facts CIK 1158895 CUSIP 525558201 13F (30d) 203 filings 202 filers Visit website Investor relations